Influence of imatinib interruption and rechallenge on the residual disease in patients with advanced GIST: results of the BFR14 prospective French Sarcoma Group randomised, phase III trial

Nom du journal : Ann Oncol

Année : 2013

Volume : 24

Page de départ : 1087

Page de fin : 1093

Auteurs: Patrikidou A, Chabaud S, Ray-Coquard I, Bui BN, Adenis A, Rios M, Bertucci F, Duffaud F, Chevreau C, Cupissol D, Dômont J, Pérol D, Blay JY, Le Cesne A, for the French Sarcoma Group, Montaudon M,